Axsome Thera (AXSM)
80.05 -2.52 (-3.05%) 01/10/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 82.00 +1.95 (+2.44%) 01/10/25
for Fri, Jan 10th, 2025
Fiscal Year End Date: 12/31
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Operating Expenses | 38,289 | 32,608 | 33,407 | 30,848 | 27,844 |
Operating Income | -38,289 | -32,608 | -33,407 | -30,848 | -27,844 |
Interest Expense | 1,343 | 1,368 | 1,476 | 1,437 | 1,416 |
Pre-tax Income | -39,632 | -33,976 | -34,883 | -32,284 | -29,260 |
Net Income Continuous | -39,632 | -33,976 | -34,883 | -32,284 | -29,260 |
Net Income | $-39,632 | $-33,976 | $-34,883 | $-32,284 | $-29,260 |
EPS Basic Total Ops | -1.03 | -0.90 | -0.93 | -0.86 | -0.78 |
EPS Basic Continuous Ops | -1.03 | -0.90 | -0.93 | -0.86 | -0.78 |
EPS Diluted Total Ops | -1.03 | -0.90 | -0.93 | -0.86 | -0.78 |
EPS Diluted Continuous Ops | -1.03 | -0.90 | -0.93 | -0.86 | -0.78 |
EBITDA(a) | $-37,754 | $-33,155 | $-32,816 | $-30,286 | $-27,297 |